On Invalid Date, Affimed Nv (NASDAQ: AFMD) reported Q4 2023 earnings per share (EPS) of -$1.54, up 35.21% year over year. Total Affimed Nv earnings for the quarter were -$22.45 million. In the same quarter last year, Affimed Nv's earnings per share (EPS) was -$2.38.
As of Q2 2024, Affimed Nv's earnings has grown year over year. Affimed Nv's earnings in the past year totalled -$115.15 million.
What is AFMD's earnings date?
Affimed Nv's earnings date is Invalid Date. Add AFMD to your watchlist to be reminded of AFMD's next earnings announcement.
What was AFMD's revenue last quarter?
On Invalid Date, Affimed Nv (NASDAQ: AFMD) reported Q4 2023 revenue of $458.89 thousand up 96.13% year over year. In the same quarter last year, Affimed Nv's revenue was $11.87 million.
What was AFMD's revenue growth in the past year?
As of Q2 2024, Affimed Nv's revenue has grown -79.1% year over year. This is 224.83 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Affimed Nv's revenue in the past year totalled $8.99 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.